The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease

• Published in: Infection & chemotherapy Vol. 52; no. 2; pp. 252 - 280
• Main Authors: Seo, Yu Bin, Moon, Su-Jin, Jeon, Chan Hong, Song, Joon Young, Sung, Yoon-Kyoung, Jeong, Su Jin, Kwon, Ki Tae, Kim, Eu Suk, Kim, Jae-Hoon, Kim, Hyoun-Ah, Park, Dong-Jin, Park, Sung-Hoon, Park, Jin Kyun, Ahn, Joong Kyong, Oh, Ji Seon, Yun, Jae Won, Lee, Joo-Hyun, Lee, Hee Young, Choi, Min Joo, Choi, Won Suk, Choi, Young Hwa, Choi, Jung-Hyun, Heo, Jung Yeon, Cheong, Hee Jin, Lee, Shin-Seok
• Format: Journal Article
• Language: English
• Published: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 01.06.2020; 대한감염학회
• Subjects: Special; 내과학
• ISSN: 2093-2340; 1598-8112; 2092-6448; 2092-6448
• DOI: 10.3947/ic.2020.52.2.252

To develop a clinical practice guideline for vaccination in patients with autoimmune inflammatory rheumatic disease (AIIRD), the Korean College of Rheumatology and the Korean Society of Infectious Diseases developed a clinical practice guideline according to the clinical practice guideline development manual. Since vaccination is unlikely to cause AIIRD or worsen disease activities, required vaccinations are recommended. Once patients are diagnosed with AIIRD, treatment strategies should be established and, at the same time, monitor their vaccination history. It is recommended to administer vaccines when the disease enters the stabilized stage. Administering live attenuated vaccines in patients with AIIRD who are taking immunosuppressants should be avoided. Vaccination should be considered in patients with AIIRD, prior to initiating immunosuppressants. It is recommended to administer influenza, Streptococcus pneumoniae, hepatitis A, hepatitis B, herpes zoster, measles-mumps-rubella virus, human papillomavirus, and tetanus-diphtheria-pertussis vaccines in patients with AIIRD; such patients who planned to travel are generally recommended to be vaccinated at the recommended vaccine level of healthy adults. Those who live in a household with patients with AIIRD and their caregivers should also be vaccinated at levels that are generally recommended for healthy adults.To develop a clinical practice guideline for vaccination in patients with autoimmune inflammatory rheumatic disease (AIIRD), the Korean College of Rheumatology and the Korean Society of Infectious Diseases developed a clinical practice guideline according to the clinical practice guideline development manual. Since vaccination is unlikely to cause AIIRD or worsen disease activities, required vaccinations are recommended. Once patients are diagnosed with AIIRD, treatment strategies should be established and, at the same time, monitor their vaccination history. It is recommended to administer vaccines when the disease enters the stabilized stage. Administering live attenuated vaccines in patients with AIIRD who are taking immunosuppressants should be avoided. Vaccination should be considered in patients with AIIRD, prior to initiating immunosuppressants. It is recommended to administer influenza, Streptococcus pneumoniae, hepatitis A, hepatitis B, herpes zoster, measles-mumps-rubella virus, human papillomavirus, and tetanus-diphtheria-pertussis vaccines in patients with AIIRD; such patients who planned to travel are generally recommended to be vaccinated at the recommended vaccine level of healthy adults. Those who live in a household with patients with AIIRD and their caregivers should also be vaccinated at levels that are generally recommended for healthy adults.